Literature DB >> 33616775

Ischemic proctitis 6 months after laparoscopic sigmoidectomy: a case report.

Takuto Yoshida1, Nobuki Ichikawa2, Shigenori Homma1, Tadashi Yoshida1, Shin Emoto1, Yoichi Miyaoka1, Hiroki Matsui1, Akinobu Taketomi1.   

Abstract

BACKGROUND: Ischemic colitis is a common disease; however, its pathophysiology remains unclear, especially in ischemic proctitis after sigmoidectomy. We present a rare case of ischemic proctitis 6 months after laparoscopic sigmoidectomy. CASE
PRESENTATION: The patient was a 60-year-old man with hypertension, type 2 diabetes, and hyperlipidemia. He was a smoker. He underwent laparoscopic sigmoidectomy for pathological stage I sigmoid colon cancer and was followed up without any adjuvant therapy. Six months after his surgery, he complained of lower abdominal discomfort, bloody stools, and tenesmus. Colonoscopy showed extensive rectal ulcers between the anastomotic site and the anal canal, which was particularly severe on the anal side several centimeters beyond the anastomosis. We provided non-surgical management, including hyperbaric oxygen therapy. The rectal ulcers had healed 48 days after the therapeutic intervention. He has not experienced any recurrence for 3.5 years.
CONCLUSIONS: While performing sigmoidectomy, it is important to consider the blood backflow from the anal side of the bowel carefully, especially for patients with risk factors of ischemic proctitis.

Entities:  

Keywords:  Bloody stool; Hyperbaric oxygen therapy; Ischemic colitis; Ischemic proctitis; Laparoscopic sigmoidectomy; Non-surgical management; Sigmoid colon cancer

Year:  2021        PMID: 33616775     DOI: 10.1186/s40792-021-01133-7

Source DB:  PubMed          Journal:  Surg Case Rep        ISSN: 2198-7793


  2 in total

1.  Ischemic proctosigmoiditis.

Authors:  A E Bharucha; W J Tremaine; C D Johnson; K P Batts
Journal:  Am J Gastroenterol       Date:  1996-11       Impact factor: 10.864

2.  A case of rectal Dieulafoy's ulcer and successful endoscopic sclerotherapy.

Authors:  J Matsuoka; K Taniai; K Kojima; M Kenmotsu; K Takai; T Okabe; N Tanaka
Journal:  Acta Med Okayama       Date:  2000-12       Impact factor: 0.892

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.